Home > Boards > US OTC > Biotechs > Oncotelic Therapeutics Inc. (OTLC)

A message relayed

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Globewriter Member Profile
 
Followed By 10
Posts 225
Boards Moderated 0
Alias Born 01/24/20
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 12/23/2021 5:01:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/15/2021 5:00:58 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/24/2021 7:07:40 AM
Mateon Therapeutics EPS beats by $0.01 Seeking Alpha - 11/23/2021 7:43:16 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/22/2021 5:02:02 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 11/15/2021 5:23:51 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/28/2021 7:00:59 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/4/2021 7:16:42 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/27/2021 5:16:27 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 9/27/2021 6:01:56 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/8/2021 5:02:06 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/8/2021 5:02:05 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/8/2021 5:02:04 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/8/2021 5:01:39 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/8/2021 7:01:42 AM
Securities Registration Statement (simplified Form) (s-3/a) Edgar (US Regulatory) - 9/8/2021 6:04:21 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/3/2021 7:01:29 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/26/2021 7:32:15 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 8/20/2021 5:03:59 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/20/2021 4:32:44 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 8/16/2021 5:20:06 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/20/2021 6:02:02 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/16/2021 5:39:44 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/16/2021 5:38:23 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/2/2021 5:16:27 PM
Globewriter   Thursday, 07/23/20 10:03:53 PM
Re: mick post# 231
Post # of 896 
A message relayed
“It seems that Steve King and Mateon have been getting some attention lately and when is the PR scheduled for the Covid-19 Clinical trial and CA4P just another surprise pending - as Steve King was collaborating long ago with OXiGene ( name changed to Mateon ) and Oncotelic founders know well of Celgene / Abraxane ties : this all leads quite the run up from .25 and instant $1+ stock. “

OT-101 is also being deployed as anti-COVID-19 agent. The IND for COVID-19 has been submitted and we plan to initiate the clinical trial as soon as possible.
http://investor.mateon.com/news-releases/news-release-details/fda-grants-pediatric-disease-designation-mateons-ca4p



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences